ArticleBiomolecules2021
Clinically Applicable Cyclotron-Produced Gallium-68 Gives High-Yield Radiolabeling of DOTA-Based Tracers.
Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.
- PSMA PET/CT imaging for biochemical recurrence in prostate cancer: can it replace conventional imaging and guide salvage therapy?Annals of nuclear medicine · 2026Pooled it
- Comparison ofProstate cancer and prostatic diseases · 2024Pooled it
- Kinetic modelling of [⁶⁸Ga]Ga-FAPI-46 PET in pancreaticobiliary lesions: distinguishing cancer from pancreatitis.European journal of nuclear medicine and molecular imaging · 2026Article
- Evaluation of Cyclotron Solid Target Produced Gallium-68 Chloride for the Labeling of [Molecules (Basel, Switzerland) · 2025Article
- Semiquantitative Analysis in PET/CT Imaging of Prostate Cancer.Journal of clinical medicine · 2025Review
- Rapid fabrication and dissolution of pressedEJNMMI radiopharmacy and chemistry · 2025Article
- Advancements in Microfluidic Cassette-Based iMiDEV™ Technology for Production of L-[Pharmaceuticals (Basel, Switzerland) · 2024Article
- Development of a versatile [Frontiers in chemistry · 2024Article
- Microfluidic-based production of [EJNMMI radiopharmacy and chemistry · 2023Article
- Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [EJNMMI radiopharmacy and chemistry · 2023Article
- Fully automated radiolabeling of [EJNMMI radiopharmacy and chemistry · 2023Article
- PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual Reproducibility.Molecular imaging and biology · 2023Article
- Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides forPharmaceutics · 2023Article
- Good practices forEJNMMI radiopharmacy and chemistry · 2022Review
- Analysis of Pros and Cons in Using [Molecules (Basel, Switzerland) · 2022Article
- Cold Kit Labeling: The Future ofFrontiers in medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
By using solid targets in medical cyclotrons, it is possible to produce large amounts of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.